Ozempic lawsuits, explained: what the GLP-1 injury claims are about

Ozempic semaglutide by Novo Nordisk

By the GLP Index editorial team Updated How we source

Ozempic lawsuits center on claims that the makers under-warned about severe gastrointestinal injuries. Here's who's suing, the current status, and what it means if you take it.

What are the Ozempic lawsuits about?

The lawsuits are not about whether Ozempic works — they’re about warnings. Plaintiffs allege that Novo Nordisk (and, in related cases, other GLP-1 makers) knew or should have known about the risk of severe gastrointestinal injuries and did not warn patients or doctors clearly enough.

The injuries most often named:

  • Gastroparesis — a condition where the stomach empties far too slowly, sometimes called “stomach paralysis,” causing severe nausea, vomiting, and pain.
  • Ileus / intestinal blockage — the gut stops moving food along normally.
  • Severe, recurrent vomiting and its complications.

A separate and newer line of claims concerns NAION (non-arteritic anterior ischemic optic neuropathy), a rare form of sudden vision loss, raised after a 2024 study reported a possible association. This claim is earlier-stage and less settled than the gastrointestinal one.

Who is filing them, and how are they organized?

The plaintiffs are individuals who took Ozempic, Wegovy, or other GLP-1 drugs and say they were seriously injured. Because so many similar suits were filed, the federal cases were consolidated into multidistrict litigation (MDL) — many individual lawsuits managed together before a single judge to streamline discovery and early rulings.

An MDL is not a class action. Each person’s case remains their own; the consolidation just handles the shared questions (what the companies knew, when, and what the science shows) in one place. A small group of “bellwether” cases is typically tried first to signal how the rest might resolve.

What’s the current status?

As of this writing, the litigation is in its pre-trial phase — discovery and expert evidence, with no jury verdicts and no announced settlements. Novo Nordisk denies the allegations and points to the warnings already on the label. Nothing here is decided, and timelines in pharmaceutical MDLs run for years.

What it means if you take Ozempic

A lawsuit is a legal claim, not a recall — Ozempic remains FDA-approved and widely prescribed. The practical takeaways:

  • Don’t stop on your own. If you’re concerned, talk to your prescriber first; stopping abruptly has its own consequences.
  • Know the red-flag symptoms. Severe abdominal pain that won’t quit, persistent vomiting, or an inability to keep food down are always call-your-provider symptoms — see our Ozempic side effects guide.
  • Report problems. The FDA’s MedWatch program exists for exactly this.

This is general information, not legal advice. Whether anyone has a claim depends on their specific medical history and the law in their state. If you believe you were harmed, consult a licensed attorney.

FAQ

Common questions about Ozempic lawsuits

Is there a class action lawsuit against Ozempic?

Not exactly. The cases are grouped as multidistrict litigation (MDL) — many individual lawsuits consolidated before one federal judge for efficiency — rather than a single class action. Each plaintiff's claim stays individual, which matters for how any future compensation would work.

What is the Ozempic lawsuit about?

The core claim is that the manufacturers failed to adequately warn patients and doctors about the risk of severe gastrointestinal injuries — including gastroparesis (sometimes called stomach paralysis), severe recurrent vomiting, and intestinal blockages. A separate, newer line of claims concerns a rare vision condition (NAION).

Have there been any Ozempic settlements?

As of this writing, no — the litigation is in its pre-trial stages, and there have been no announced settlements or jury verdicts. The companies deny the allegations. Treat any site advertising guaranteed payouts with skepticism.

Should I stop taking Ozempic because of the lawsuits?

Not on your own. A lawsuit is a legal claim, not a safety recall — Ozempic remains FDA-approved. If you're worried about symptoms, talk to your prescriber, and report side effects to the FDA's MedWatch program. Never stop a prescribed medication based on headlines alone.

Sources

Every claim on this page traces to primary literature or FDA labeling. Browse the full evidence library.

  1. Ozempic prescribing information (FDA label) (Novo Nordisk / FDA)
  2. FDA MedWatch — report a side effect (U.S. Food & Drug Administration)
This page is for informational purposes only and isn't medical advice. Talk to a licensed healthcare provider about your situation before starting, stopping, or changing any medication. See our medical disclaimer and editorial policy.

Written by the GLP Index editorial team · Updated July 23, 2026 · How we source